Synapse - Jonathan Rosenberg

Results (520)

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Post-progression outcomes from the phase II IMvigor210 study

Journal Article

Necchi, A.; Joseph, R. W.; Loriot, Y.; Hoffman-Censits, J.; Perez-Gracia, J. L.; Petrylak, D. P.; Derleth, C. L.; Tayama, D.; Zhu, Q.; Ding, B.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets

Journal Article

Pietzak, E. J.; Bagrodia, A.; Cha, E. K.; Drill, E. N.; Iyer, G.; Isharwal, S.; Ostrovnaya, I.; Baez, P.; Li, Q.; Berger, M. F.; more...
European Urology (2017)

Fulltext@MSK | Save

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer

Journal Article

Liu, D.; Abbosh, P.; Keliher, D.; Reardon, B.; Miao, D.; Mouw, K.; Weiner-Taylor, A.; Wankowicz, S.; Han, G.; Teo, M. Y.; more...
Nature Communications (2017)

Fulltext@MSK | Save

Mapping the functional landscape of ERCC2 mutations in muscle-invasive bladder cancer

Meeting Abstract

Frazier, Z.; Damish, A.; Reznichenko, E.; Liu, D.; Rosenberg, J.; Van Allen, E.; Lazaro, J. B.; D'Andrea, A. D.; Mouw, K.
International Journal of Radiation Oncology, Biology, Physics (2017)

Fulltext@MSK | Save

Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline

Journal Article

Chang, S. S.; Bochner, B. H.; Chou, R.; Dreicer, R.; Kamat, A. M.; Lerner, S. P.; Lotan, Y.; Meeks, J. J.; Michalski, J. M.; Morgan, T. M.; more...
Journal of Urology (2017)

Fulltext@MSK | Save

Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy

Meeting Abstract

v. Amsberg, G.; Perez-Garcia, J. L.; Loriot, Y.; Rosenberg, J. E.; Powles, T.; Necchi, A.; Hussain, S. A.; Morales-Barrera, R.; Retz, M.; Niegisch, G.; more...
Oncology Research and Treatment (2017)

Fulltext@MSK | Save

Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Post-progression outcomes from the phase 2 IMvigor210 study

Meeting Abstract

Necchi, A.; Joseph, R. W.; Loriot, Y.; Hoffman-Censits, J.; Perez Gracia, J. L.; Petrylak, D. P.; Zhu, Q.; Ding, B.; Kaiser, C.; Rosenberg, J. E.
Annals of Oncology (2017)

Fulltext@MSK | Save

Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population

Meeting Abstract

Necchi, A.; Pond, G. R.; Pal, S. K.; Agarwal, N.; Bowles, D.; Plimack, E.; Yu, E. Y.; Ladoire, S.; Baniel, J.; Crabb, S.; more...
Annals of Oncology (2017)

Fulltext@MSK | Save

Impact of cisplatin-based therapy on long-term survival in advanced urinary tract cancer (aUTC). A retrospective international study of invasive/advanced cancer of the urothelium (RISC)